View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 8, 2022

Medable and CVS Health partner to boost access to clinical trials

The collaboration will combine Medable's software platform and CVS Health’s community reach and MinuteClinic providers.

Medable and CVS Health have entered a collaboration to extend clinical trial access and engagement for patients at chosen MinuteClinic locations through Medable’s clinical trials software platform. 

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

Managed by CVS Health Clinical Trial Services, the collaboration will bring together the software platform, CVS Health’s community reach and MinuteClinic providers.

This alliance is aimed at providing trials that boost patient access, engagement and retention, thereby improving the effectiveness of the research.

The varied workforce of CVS Health can aid in enhancing the care delivery and clinical trial services that are culturally inclusive, Medable stated.

CVS Health Clinical Trial Services (CTS) has been designing and offering novel methods to research and real-world data generation by collaborating with crucial stakeholders in the biopharmaceutical sector and across the trial ecosystem since May last year. 

As part of the latest partnership, CVS Health will provide precision patient recruitment using innovative analytics, national reach, and local community connections.

Furthermore, CVS Health will provide decentralised options for the delivery of Phase III/IV trials, as well as real-world evidence studies at the select MinuteClinic locations, in-home using its Coram home health services team, and virtually. 

Medable chief growth officer Sans Thakur said: “This collaboration intends to bridge research and science into communities with local access and experience that builds greater trust in health and medicine.

“Practical applications of Medable technology with the reach and experience of CVS Health gives us an opportunity to harness this time of change and respond differently to unmet needs in local communities.”

In December last year, Medable partnered with Vault Health to combine the former’s end-to-end software platform with the latter’s expertise in diagnostics, logistics and remote care services for decentralised trials.

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena